Stomatitis har været rapporteret hos patienter i behandling med kontinuerlige infusioner af konventionel doxorubicinhydrochlorid og var hyppigt rapporteret hos patienter i Caelyx- behandling.
Stomatitis has been reported in patients receiving continuous infusions of conventional doxorubicin hydrochloride and was frequently reported in patients receiving Caelyx.